1. Home
  2. SDOT vs REVB Comparison

SDOT vs REVB Comparison

Compare SDOT & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sadot Group Inc.

SDOT

Sadot Group Inc.

N/A

Current Price

$2.07

Market Cap

4.9M

ML Signal

N/A

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$1.27

Market Cap

5.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDOT
REVB
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SDOT
REVB
Price
$2.07
$1.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.6K
213.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
490.91
N/A
EPS
N/A
N/A
Revenue
$7,929,137.00
N/A
Revenue This Year
$12.76
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
60.08
N/A
52 Week Low
$0.72
$0.47
52 Week High
$13.02
$3.80

Technical Indicators

Market Signals
Indicator
SDOT
REVB
Relative Strength Index (RSI) 36.00 44.07
Support Level $1.18 $0.77
Resistance Level $2.40 $1.38
Average True Range (ATR) 0.19 0.09
MACD -0.05 -0.04
Stochastic Oscillator 7.06 0.00

Price Performance

Historical Comparison
SDOT
REVB

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: